Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis

pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections

research and development of pharmaceutical products and preparations for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections

research and development of pharmaceutical products and preparations for the treatment of atherosclerosis

pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections

Research and development of pharmaceutical products and preparations for the treatment of hypertension, hypercholesterolemia, depression, atherosclerosis, thyroid deficiency syndrome, organ rejection, hepatitis and, HIV and fungal infections

Research and development of pharmaceutical products and preparations for the treatment of hypertension, hypercholesterolemia, depression, atherosclerosis, thyroid deficiency syndrome, organ rejection, hepatitis and, HIV and fungal infections

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis

pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of atherosclerosis